Skip to main content
Fig. 2 | Head & Face Medicine

Fig. 2

From: The anti-tumor effect of proteasome inhibitor MG132 for human adenoid cystic carcinoma: correlate with the emerging role of Nrf2/Keap1 signaling pathway

Fig. 2

Assessment of apoptosis by annexin V/PI and flow cytometry in ACC-83 cells treated with MG132 (10, 40, 70,µM) for 12 h. The group incubated with complete 1640 medium was used as the control group. As the concentration of the drug increased, the apoptosis rate of ACC-83 cells increased. *P < 0.05,**P < 0.01 versus control

Back to article page

Head & Face Medicine

ISSN: 1746-160X

Contact us